A German study involving 901 people living with early multiple sclerosis (MS) has found that 100% of participants had antibodies against the Epstein-Barr virus (EBV). Performed by researchers at Charité - Universitätsmedizin Berlin, this research provides further compelling evidence that infection with EBV may play a role in multiple sclerosis. In this video, MStranslate co-founder and chief science communicator, Brett Drummond, discusses the outcomes of this published paper in more detail and explains the potential implications of the findings.
If you have any questions for Brett, please either comment below or email them to him directly at brett@mstranslate.com.au.
Learn more about MStranslate via the below links:
Website: mstranslate.co...
Facebook: / mstranslate
Twitter: / mstranslate
Instagram: / mstranslate
LinkedIn: / mstranslate
Негізгі бет Epstein-Barr Virus & Multiple Sclerosis: New Study Outcomes
Пікірлер: 49